Cidara Therapeutics’ (CDTX) “Market Outperform” Rating Reiterated at JMP Securities
JMP Securities reiterated their market outperform rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a research report released on Tuesday morning,Benzinga reports. The brokerage currently has a $47.00 target price on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on CDTX. Citizens Jmp started coverage on […]
JMP Securities reiterated their market outperform rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a research report released on Tuesday morning,Benzinga reports. The brokerage currently has a $47.00 target price on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on CDTX. Citizens Jmp started coverage on […]
